MORGAN SADLER: Open Payments
NPI 1336854207 · WESTMORELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,944 in 113 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,394 · 2025 $1,944
Food & beverage: $1,944
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $288 |
| AstraZeneca Pharmaceuticals LP | 13 | $286 |
| Otsuka America Pharmaceutical, Inc. | 13 | $194 |
| Novo Nordisk Inc | 11 | $180 |
| Mannkind Corporation | 6 | $153 |
| Lundbeck LLC | 6 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $131 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| PFIZER INC. | 3 | $60 |
Products named: REXULTI, AFREZZA, UBRELVY, AIRSUPRA, CAPLYTA, Ozempic, VRAYLAR, BREZTRI.
Industry payments across TN — which companies pay providers there.
